Long term outcomes of occipital nerve stimulation
- PMID: 37021077
- PMCID: PMC10067723
- DOI: 10.3389/fpain.2023.1054764
Long term outcomes of occipital nerve stimulation
Abstract
Background: Occipital nerve stimulation (ONS) has been investigated as a potential treatment for disabling headaches and has shown promise for disorders such as chronic migraine and cluster headache. Long term outcomes stratified by headache subtype have had limited exploration, and literature on outcomes of this neuromodulatory intervention spanning 2 or more years is scarce.
Measures: We performed a narrative review on long term outcomes with ONS for treatment of headache disorders. We surveyed the available literature for studies that have outcomes for 24 months or greater to see if there is a habituation in response over time. Review of the literature revealed evidence in treatment of occipital neuralgia, chronic migraine, cluster headache, cervicogenic headache, short lasting unilateral neuralgiform headache attacks (SUNHA) and paroxysmal hemicrania. While the term "response" varied per individual study, a total of 17 studies showed outcomes in ONS with long term sustained responses (as defined per this review) in the majority of patients with specific headache types 177/311 (56%). Only 7 studies in total (3 cluster, 1 occipital neuralgia, 1 cervicogenic headache, 1 SUNHA, 1 paroxysmal hemicrania) provided both short-term and long-term responses up to 24 months to ONS. In cluster headache, the majority of patients (64%) were long term responders (as defined per this review) and only a minority of patients 12/62 (19%) had loss of efficacy (e.g., habituation). There was a high number 313/439 (71%) of adverse events per total number of patients in the studies including lead migration, requirements of revision surgery, allergy to surgical materials, infection and intolerable paresthesias.
Conclusions: With the evidence available, the response to ONS was sustained in the majority of patients with cluster headache with low rates of loss of efficacy in this patient population. There was a high percent of adverse events per number of patients in long term follow-up and likely related to the off-label use of leads typically used for spinal cord stimulation. Further longitudinal assessments of outcomes in occipital nerve stimulation with devices labelled for use in peripheral nerve stimulation are needed to evaluate the extent of habituation to treatment in headache.
Keywords: habituation; headache; long term outcomes; neuromodulation; occipital nerve stimulation.
© 2023 Montenegro and Kissoon.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Four Decades of Occipital Nerve Stimulation for Headache Disorders: A Systematic Review.Curr Pain Headache Rep. 2024 Oct;28(10):1015-1034. doi: 10.1007/s11916-024-01271-1. Epub 2024 Jun 22. Curr Pain Headache Rep. 2024. PMID: 38907793
-
Long-term follow up of intractable chronic short lasting unilateral neuralgiform headache disorders treated with occipital nerve stimulation.Cephalalgia. 2018 Apr;38(5):933-942. doi: 10.1177/0333102417721716. Epub 2017 Jul 14. Cephalalgia. 2018. PMID: 28708008
-
Efficacy of Occipital Nerve Stimulation to Treat Refractory Occipital Headaches: A Single-Institution Study of 60 Patients.Neuromodulation. 2020 Aug;23(6):789-795. doi: 10.1111/ner.13223. Epub 2020 Jul 28. Neuromodulation. 2020. PMID: 32725745
-
Occipital Nerve Stimulation for Refractory Chronic Migraine: Results of a Long-Term Prospective Study.Pain Physician. 2017 Jan-Feb;20(1):E151-E159. Pain Physician. 2017. PMID: 28072807
-
Cluster headache and other TACs: Pathophysiology and neurostimulation options.Headache. 2017 Feb;57(2):327-335. doi: 10.1111/head.12874. Epub 2016 Aug 4. Headache. 2017. PMID: 28128461 Review.
Cited by
-
Histopathological changes in tissues surrounding vagal nerve stimulation generators: A retrospective analysis of revision surgeries.Acta Neurochir (Wien). 2023 Aug;165(8):2171-2178. doi: 10.1007/s00701-023-05701-8. Epub 2023 Jul 2. Acta Neurochir (Wien). 2023. PMID: 37393559
-
Four Decades of Occipital Nerve Stimulation for Headache Disorders: A Systematic Review.Curr Pain Headache Rep. 2024 Oct;28(10):1015-1034. doi: 10.1007/s11916-024-01271-1. Epub 2024 Jun 22. Curr Pain Headache Rep. 2024. PMID: 38907793
-
Occipital nerve stimulation in medically intractable chronic cluster headache.Eur J Neurol. 2024 Mar;31(3):e16212. doi: 10.1111/ene.16212. Epub 2024 Jan 17. Eur J Neurol. 2024. PMID: 38230580 Free PMC article. No abstract available.
-
Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine.Front Neurol. 2023 Sep 27;14:1263535. doi: 10.3389/fneur.2023.1263535. eCollection 2023. Front Neurol. 2023. PMID: 37830088 Free PMC article. Review.
-
Occipital nerve stimulation for cluster headache: lessons to learn from the 'voltage tuners'.J Headache Pain. 2024 Aug 23;25(1):139. doi: 10.1186/s10194-024-01839-7. J Headache Pain. 2024. PMID: 39180011 Free PMC article.
References
-
- Strand N, D'Souza RS, Hagedorn JM, Pritzlaff S, Sayed D, Azeem N, et al. Evidence-Based clinical guidelines from the American society of pain and neuroscience for the use of implantable peripheral nerve stimulation in the treatment of chronic pain. J Pain Res. (2022) 15:2483–504. 10.2147/JPR.S362204 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources